Ver mas grande
MAPK14 antibody
FT-FNab06076
Producto nuevo
100 µg
Comprando este producto generará 1 Biopunto. Su cesta contiene un total 1 Biopunto puede ser convertido en un Biobonos Descuento 4.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IF, IHC |
| Target | MAPK14 |
| Research Area | Immunology, Cardiovascular, Metabolism, Signal Transduction |
| Form | liquid |
| Recomended Dilution | WB: 1:200-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | mitogen-activated protein kinase 14 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Mitogen-activated protein kinase 14 (MAP kinase 14, MAPK 14)|Cytokine suppressive anti-inflammatory drug-binding protein (CSAID-binding protein, CSBP)|MAP kinase MXI2|MAX-interacting protein 2|Mitogen-activated protein kinase p38 alpha (MAP kinase p38 alp |
| Host | Rabbit |
| UniProt ID | Q16539 |
| Gene ID | 1432 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 41 kDa |
| Background | MAPK14 (mitogen-activated protein kinase 14) is also named as SAPK2A, p38MAPK, CSBP1, RK, p38, EXIP, Mxi2, CSBP2, PRKM14, PRKM15, CSPB1, p38ALPHA and belongs to the MAP kinase subfamily. MAPK14-signaling is a central pathway for the integration of instruc |
Más información
p38 antibody